PLANT ADVANCED TECHNOLOGIES |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.2 EUR | +2.00% |
|
-0.97% | +20.71% |
| Sales 2023 * | 2.3M 2.45M | Sales 2024 * | 2.6M 2.77M | Capitalization | 10.87M 11.59M |
|---|---|---|---|---|---|
| Net income 2023 * | - 0 | Net income 2024 * | - | EV / Sales 2023 * | 7.16 x |
| Net Debt 2023 * | 5.6M 5.97M | Net Debt 2024 * | 3.3M 3.52M | EV / Sales 2024 * | 5.45 x |
| P/E ratio 2023 * |
-14.9
x | P/E ratio 2024 * |
-500
x | Employees | 56 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 51.42% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | +2.00% | ||
| 1 week | -0.97% | ||
| Current month | +21.43% | ||
| 1 month | +109.02% | ||
| 3 months | +82.14% | ||
| 6 months | +4.08% | ||
| Current year | +20.71% |
1 week
9.80
10.20
1 month
4.8810.80
Current year
2.9010.80
1 year
2.9014.00
3 years
2.9025.00
5 years
2.9033.40
10 years
2.9033.40
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | 59 | 05-06-29 | |
Jean-Paul Fèvre
CEO | Chief Executive Officer | 70 | 05-06-29 |
Régis Brun
DFI | Director of Finance/CFO | 78 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Thierry Chapusot
BRD | Director/Board Member | 65 | 15-06-29 |
Viviane Neiter
BRD | Director/Board Member | 68 | 15-06-29 |
Jean-Paul Fèvre
CEO | Chief Executive Officer | 70 | 05-06-29 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 10.2 | +2.00% | 209 |
| 24-04-18 | 10 | +2.04% | 1,103 |
| 24-04-17 | 9.8 | -0.51% | 8 |
| 24-04-16 | 9.85 | +0.51% | 1 |
| 24-04-15 | 9.8 | -4.85% | 10 |
Real-time Euronext Paris, April 19, 2024 at 11:35 am EDT
More quotes
Plant Advanced Technologies specializes in the identification, optimization and production of rare biomolecules for the pharmaceutical laboratories, cosmetic industries and green chemistry. The group has developed revolutionary production methods based on aeroponics growing plant (soilless). Innovative technologies (PAT plantes à traire - Patent INRA-University of Lorraine / INPL and PAT Friday) allow the identification of new rare molecules previously inaccessible and the industrial production.
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
10
EUR
Average target price
11.5
EUR
Spread / Average Target
+15.00%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +20.71% | 11.59M | |
| -1.62% | 41.35B | |
| +41.70% | 40.38B | |
| +3.03% | 39.05B | |
| -12.11% | 26.67B | |
| +1.94% | 24.07B | |
| -23.58% | 18.36B | |
| -3.32% | 11.68B | |
| +21.22% | 11.6B | |
| +7.36% | 11.15B |
- Stock Market
- Equities
- ALPAT Stock
